- Home
- KALV vs MHD Comparison
KALV vs MHD Comparison
Compare KALV & MHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- MHD
- Stock Information
- Founded
- KALV N/A
- MHD N/A
- Country
- KALV United States
- MHD United States
- Employees
- KALV N/A
- MHD N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- MHD Investment Bankers/Brokers/Service
- Sector
- KALV Health Care
- MHD Finance
- Exchange
- KALV Nasdaq
- MHD Nasdaq
- Market Cap
- KALV 642.3M
- MHD 592.9M
- IPO Year
- KALV N/A
- MHD N/A
- Fundamental
- Price
- KALV $14.31
- MHD $11.20
- Analyst Decision
- KALV Strong Buy
- MHD
- Analyst Count
- KALV 9
- MHD 0
- Target Price
- KALV $26.29
- MHD N/A
- AVG Volume (30 Days)
- KALV 2.0M
- MHD 124.9K
- Earning Date
- KALV 07-10-2025
- MHD 01-01-0001
- Dividend Yield
- KALV N/A
- MHD 4.16%
- EPS Growth
- KALV N/A
- MHD N/A
- EPS
- KALV N/A
- MHD N/A
- Revenue
- KALV N/A
- MHD N/A
- Revenue This Year
- KALV N/A
- MHD N/A
- Revenue Next Year
- KALV $347.19
- MHD N/A
- P/E Ratio
- KALV N/A
- MHD N/A
- Revenue Growth
- KALV N/A
- MHD N/A
- 52 Week Low
- KALV $7.30
- MHD $9.92
- 52 Week High
- KALV $16.32
- MHD $12.18
- Technical
- Relative Strength Index (RSI)
- KALV 58.58
- MHD 49.91
- Support Level
- KALV $11.10
- MHD $11.13
- Resistance Level
- KALV $16.32
- MHD $11.25
- Average True Range (ATR)
- KALV 1.10
- MHD 0.07
- MACD
- KALV 0.36
- MHD 0.01
- Stochastic Oscillator
- KALV 68.95
- MHD 54.17
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About MHD Blackrock MuniHoldings Fund Inc.
Blackrock Muniholdings Fund Inc is a closed-end management investment company. The fund's objective is to provide shareholders with current income exempt from U.S. federal income taxes. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.